Brief

The document outlines reporting guidelines for IVD blood glucose meters used in POCT or home use. Adverse incidents such as display issues, performance errors, and design/manufacturing flaws are reportable. Manufacturers must provide detailed information on each incident, including patient symptoms, meter readings, and manufacturer's actions. The final vigilance report should include a clinical assessment, manufacturer's final assessment, and corrective actions taken by the manufacturer to prevent future incidents.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies